✦ LIBER ✦

Cytotoxic T-lymphocyte antigen-4 (CTLA-4) gene polymorphism and susceptibility to non-Hodgkin's lymphoma

✍ Scribed by Maria Monne; Giovanna Piras; Angelo Palmas; Luigi Arru; Marco Murineddu; Giancarlo Latte; Annalisa Noli; Attilio Gabbas

Publisher: John Wiley and Sons
Year: 2004
Tongue: English
Weight: 100 KB
Volume: 76
Category: Article
ISSN: 0361-8609
DOI: 10.1002/ajh.20045

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cytotoxic T lymphocyte antigen-4 (CTLA-4

Cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphisms and susceptibility to type 1 autoimmune hepatitis

✍ Kosh Agarwal; Albert J. Czaja; David E. Jones; Peter T. Donaldson 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB

Genetic susceptibility to type 1 autoimmune hepatitis is indicated by a preponderance of female subjects and strong associations with human leukocyte antigens (HLA) DRB1\*0301 and DRB1\*0401. The gene encoding cytotoxic T-lymphocyte antigen-4 (CTLA-4) on chromosome 2q33 may also influence autoimmuni

Polymorphisms in the cytotoxic T-lymphoc

Polymorphisms in the cytotoxic T-lymphocyte antigen 4 gene and cancer risk : A meta-analysis

✍ Yonggang Zhang; Jie Zhang; Yao Deng; Can Tian; Xiaobo Li; Jin Huang; Hong Fan 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 546 KB

## Abstract ## BACKGROUND: Polymorphisms in the cytotoxic T‐lymphocyte antigen 4 (__CTLA‐4__) gene have been implicated in susceptibility to cancer, but the many published studies have reported inconclusive results. The objective of the current study was to conduct a meta‐analysis investigating th

Carriage of a tumor necrosis factor poly

Carriage of a tumor necrosis factor polymorphism amplifies the cytotoxic T-lymphocyte antigen 4 attributed risk of primary biliary cirrhosis: Evidence for a gene–gene interaction

✍ Brian D. Juran; Elizabeth J. Atkinson; Joseph J. Larson; Erik M. Schlicht; Xiang 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 180 KB

Common genetic variants significantly influence complex diseases such as primary biliary cirrhosis (PBC). We recently reported an association between PBC and a single nucleotide polymorphism (rs231725) of the immunoreceptor gene cytotoxic T-lymphocyte antigen 4 (CTLA4). We hypothesized that PBC risk

HOW TO DIFFERENTIATE BETWEEN T-CELL-RICH

HOW TO DIFFERENTIATE BETWEEN T-CELL-RICH B-CELL LYMPHOMA AND LYMPHOCYTE-PREDOMINANT HODGKIN'S DISEASE. EVIDENCE FOR THE VALUE OF MB1 AND 4KB5 IMMUNOSTAINING

✍ SCHMIDT, U.; HERBST, J.; METZ, K. A.; LEDER, L.-D. 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 843 KB

Striking morphological similarities exist between T-cell-rich B-cell lymphoma and lymphocyte-predominant Hodgkin's disease (Hodgkin's paragranuloma), making the distinction between them extremely difficult. Immunohistochemistry proFides a means of overcoming this difficult!. lmmunostaining with UCHL

AUTHORS' REPLY. HOW TO DIFFERENTIATE BET

AUTHORS' REPLY. HOW TO DIFFERENTIATE BETWEEN T-CELL-RICH B-CELL LYMPHOMA AND LYMPHOCYTE-PREDOMINANT HODGKIN'S DISEASE. EVIDENCE FOR THE VALUE OF MB1 AND 4KB5 IMMUNOSTAINING

✍ SCHMIDT, U.; HERBST, J.; METZ, K. A.; LEDER, L.-D. 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 159 KB 👁 2 views

We thank Drs Ashton-Key and Isaacson for their interest in our paper. In a similar study on CD45 immunostaining of TCRBCL and LPHD, they found L+H cells positive for either CD45RA (4KB5, 5/12) or CD45RO (UCHL1,7/12). In our series, the L+H cells were found to be 4KB5-as well as UCHL1-negative in 8/1